Kurvelo Kit
Product Images NDC 50090-6374

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Kurvelo (NDC 50090-6374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Levonorgestrel (12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 01)

Chemical structure diagram of the active ingredient ethinyl estradiol, showing its steroid backbone with hydroxyl and ethynyl functional groups.*

FDA Label Image

Ethinyl Estradiol (12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 02)

Chemical structure diagram of the active ingredient ethinyl estradiol, showing its molecular configuration with labeled functional groups and bonds.*

FDA Label Image

Image (12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 03)

A horizontal bar chart depicting the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC User (1 to 5), COC User (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) with the highest range from 40 to 65. An explanatory note clarifies that pregnancy data is based on actual pregnancy duration in referenced studies and uses a model assumption of nine months for pregnancy duration.*

FDA Label Image

Image (12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 04)

A forest plot chart displaying risk estimates for breast cancer associated with combined oral contraceptive use from various studies. The horizontal axis shows effect estimates (odds ratios/relative risks) ranging approximately from -1.5 to 2, with multiple study results plotted as points with confidence intervals. Study names and years are listed on the left, with corresponding effect estimates and confidence intervals on the right.*

FDA Label Image

Image (12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 05)

A vertical arrow chart illustrating pregnancy rates per 100 women in one year, ranging from fewer than 1 to 85 or more pregnancies. The chart categorizes birth control methods by effectiveness: the top box lists implants, injections, intrauterine devices, and sterilization; the second box highlights birth control pills, skin patch, and vaginal ring with hormones; the middle box includes condoms and diaphragm; the next box features no sex during fertile days, spermicide, and withdrawal; and the bottom box indicates no birth control, correlating with the highest pregnancy rates.*

FDA Label Image

Image (12a86fc2 F0c5 4617 Acb1 4e2bd2fd3718 06)

An illustrated medication schedule for a 28-day oral contraceptive pill kit showing four weekly rows labeled Week 1 to Week 4, each with seven circles representing days of the week from Sunday to Saturday. Arrows indicate the pill-taking sequence, and the right side includes a reminder for monthly self breast exam.*

FDA Label Image

Label Image (Lbl500906374)

Kurvelo kit containing levonorgestrel and ethinyl estradiol 0.15 mg/30 mcg tablets. The label includes NDC 50090-6374-0 and specifies the product as a human prescription drug by A-S Medication Solutions. The package contains 1 blister of 28 tablets and instructs storage at 77 degrees F.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.